Sign in to view content

Defining a 'Strong' and 'Weak' Response to Anti-VEGF Treatment CI-DME: Retrospective Analysis of 3 DRCR Retina Network Clinical Trials

Sharon D. Solomon, MD

Video
Published 2023

Related

Two years visual acuity and anatomical outcomes of patients with diabetic macular oedema treated with intravitreal aflibercept in a real life setting
Marko Lukic, MD PhD FEBO FASRS
On Demand Cases, Courses, and Papers
2019
Real-World Treatment Patterns in Patients With Macular Edema Due to Retinal Vein Occlusion
Vrinda S. Hershberger, MD, PhD
Annual Meeting Talks
2020
Retinal Vascular Disease Symposium
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

Anti-VEGF

See more